Here is a meta study of all the studies of sarcosine and related supplements that focus on the NMDA receptor in the brain:
Results were based on a total sample size of 1253 cases from 29 trials that fulfilled the specified criteria.
CONCLUSIONS:
Taking into consideration the number of trials and sample size in subgroup analyses, D-serine, NAC and sarcosine as adjuncts to non-clozapine antipsychotics have therapeutic benefit in the treatment of negative and total symptoms of chronic schizophrenia. While glycine improves positive and total symptoms as an adjuvant to non-clozapine antipsychotics, it worsens them when added to clozapine.
The standardized mean difference coefficient for sarcosine is less than 0.60. Not a resounding victory. It MAY have some impact, but this âmeta-analysisâ does not mention length of symptom relief or abatement.
The saying âIt wonât hurt to try itâ applies here,
and if it donât seem to help, then stop.
Okay?
Now,
on with the business of welcome.
Hello @blades8922!
Welcome to our humble site, this is just a prieview of more to come.
Hopefully, all will post and be friends,
if not,
then at least be civil and supportive.